Paper55717
Improvement in insulin secretion in diabetes after diazoxide.
Greenwood RH and 2 others. Lancet, 1976. Cited by 101 papers, by iCite.
Cite this record
ConductScience Library. Improvement in insulin secretion in diabetes after diazoxide. Papers, record 55717. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/55717
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Clinical Trial, Comparative Study, Controlled Clinical Trial, Journal Article
- PubMed
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetes Mellitus | Major topic |
| Diazoxide | Major topic |
| Insulin | Major topic |
| Administration, Oral | |
| Blood Glucose | |
| Glucagon | |
| Humans | |
| Injections, Intravenous | |
| Insulin Antagonists | |
| Insulin Secretion | |
| Islets of Langerhans | |
| Placebos | |
| Tolbutamide |
Source PubMed
Cited by48
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42415984 | Calcium dysregulation in diabetic cardiomyopathy & heart failure with preserved ejection fraction. | Front Cardiovasc Med | 2026 | https://conductscience.org/library/papers/42415984 | PubMed |
| 41800787 | Is high insulin protective or detrimental? Mathematical modeling reveals the base of the iceberg. | Am J Physiol Endocrinol Metab | 2026 | https://conductscience.org/library/papers/41800787 | PubMed |
| 39496966 | Targeting the NLRP3 inflammasome-IL-1β pathway in type 2 diabetes and obesity. | Diabetologia | 2025 | https://conductscience.org/library/papers/39496966 | PubMed |
| 39433757 | Calorie restriction increases insulin sensitivity to promote beta cell homeostasis and longevity in mice. | Nat Commun | 2024 | https://conductscience.org/library/papers/39433757 | PubMed |
| 35848461 | Beneficial metabolic effects of recurrent periods of beta-cell rest and stimulation using stable neuropeptide Y1 and glucagon-like peptide-1 receptor agonists. | Diabetes Obes Metab | 2022 | https://conductscience.org/library/papers/35848461 | PubMed |
| 35355560 | It's What and When You Eat: An Overview of Transcriptional and Epigenetic Responses to Dietary Perturbations in Pancreatic Islets. | Front Endocrinol (Lausanne) | 2022 | https://conductscience.org/library/papers/35355560 | PubMed |
| 35294000 | Genetic Reduction of Glucose Metabolism Preserves Functional β-Cell Mass in KATP-Induced Neonatal Diabetes. | Diabetes | 2022 | https://conductscience.org/library/papers/35294000 | PubMed |
| 35204835 | Nutrient Regulation of Pancreatic Islet β-Cell Secretory Capacity and Insulin Production. | Biomolecules | 2022 | https://conductscience.org/library/papers/35204835 | PubMed |
| 35196393 | ATP-Sensitive Potassium Channels in Hyperinsulinism and Type 2 Diabetes: Inconvenient Paradox or New Paradigm? | Diabetes | 2022 | https://conductscience.org/library/papers/35196393 | PubMed |
| 34407177 | The Pancreatic ß-cell Response to Secretory Demands and Adaption to Stress. | Endocrinology | 2021 | https://conductscience.org/library/papers/34407177 | PubMed |
| 33775061 | Hyperinsulinemia in Obesity, Inflammation, and Cancer. | Diabetes Metab J | 2021 | https://conductscience.org/library/papers/33775061 | PubMed |
| 32582035 | Reducing Glucokinase Activity to Enhance Insulin Secretion: A Counterintuitive Theory to Preserve Cellular Function and Glucose Homeostasis. | Front Endocrinol (Lausanne) | 2020 | https://conductscience.org/library/papers/32582035 | PubMed |
| 32191646 | Influence of adiposity, insulin resistance, and intrahepatic triglyceride content on insulin kinetics. | J Clin Invest | 2020 | https://conductscience.org/library/papers/32191646 | PubMed |
| 31501536 | Targeting innate immune mediators in type 1 and type 2 diabetes. | Nat Rev Immunol | 2019 | https://conductscience.org/library/papers/31501536 | PubMed |
| 31473158 | Ion Channels of the Islets in Type 2 Diabetes. | J Mol Biol | 2020 | https://conductscience.org/library/papers/31473158 | PubMed |
| 31187459 | Targeting Islets: Metabolic Surgery Is More than a Bariatric Surgery. | Obes Surg | 2019 | https://conductscience.org/library/papers/31187459 | PubMed |
| 31127805 | Inflammation in the Pathophysiology and Therapy of Cardiometabolic Disease. | Endocr Rev | 2019 | https://conductscience.org/library/papers/31127805 | PubMed |
| 31061431 | The role of membrane excitability in pancreatic β-cell glucotoxicity. | Sci Rep | 2019 | https://conductscience.org/library/papers/31061431 | PubMed |
| 30989320 | Islet inflammation in type 2 diabetes. | Semin Immunopathol | 2019 | https://conductscience.org/library/papers/30989320 | PubMed |
| 30630689 | Friend and foe: β-cell Ca2+ signaling and the development of diabetes. | Mol Metab | 2019 | https://conductscience.org/library/papers/30630689 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GCG | 2641 | PubTator's text mining | https://conductscience.org/library/genes/2641 | NCBI Gene |
| INS | 3630 | PubTator's text mining | https://conductscience.org/library/genes/3630 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/55717
GET https://conductscience.org/api/papers/v1/55717/cited_by?page=2